To read the full story, subscribe or sign in.

Cureon Raises DKK34M For Antisense DNA Analogue

Aug. 14, 2002

By Cormac Sheridan

BioWorld Asia

Today's news in brief

BioWorld

BioWorld briefs for Aug. 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Aug. 15, 2025.

Merck’s MK-2214 shows potential to slow Alzheimer’s pathology

BioWorld Science

Abnormal tau aggregation is a hallmark of Alzheimer’s disease (AD) and a major contributor to neurodegeneration, synaptic dysfunction, and progressive functional...

Microscopic image of blood cells, chronic myeloid leukemia and thrombocytosis

Scemblix ticks Novartis earnings box; more ahead in CML

BioWorld

Novartis AG’s financial update included good news about Scemblix (asciminib), the first and only U.S. FDA-approved allosteric inhibitor for chronic myeloid...

ONC-841 reduces SIGLEC10-mediated Aβ plaque formation

BioWorld Science

Sialic acid-binding immunoglobulin-like lectin 10 (SIGLEC10) is a microglia-specific surface receptor in the central nervous system, whose expression has been...